John W Smither E Ffector Therapeutics, Inc. (EFTR) insider trading activity

EFTR Quotes by TradingView

John W Smither is Director of eFFECTOR Therapeutics, Inc.. Currently has a direct ownership of 24,142 shares of EFTR, which is worth approximately $0. The most recent transaction as insider was on Aug 25, 2021, when has been sold 24,142 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.1K
0% 3M change
0% 12M change
Total Value Held $0

John W Smither Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2021
BUY
Grant, award, or other acquisition
-
24,142 Added 50.0%
24,142 Common Stock

Also insider at

ARQT
Arcutis Biotherapeutics, Inc. Healthcare
Chief Financial Officer
AMTI
Applied Molecular Transport Inc. Healthcare
Director
GNLX
GENELUX CORP
NAMS
NewAmsterdam Pharma Co N.V.
JWS

John W Smither

Director
Solana Beach, CA

Track Institutional and Insider Activities on EFTR

Follow eFFECTOR Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EFTR shares.

Notify only if

Insider Trading

Get notified when an E Ffector Therapeutics, Inc. insider buys or sells EFTR shares.

Notify only if

News

Receive news related to eFFECTOR Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EFTR